Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 48

Results For "immune"

589 News Found

Oxford BioDynamics launches its Checkpoint Inhibitor response test in the US
Biotech | February 27, 2022

Oxford BioDynamics launches its Checkpoint Inhibitor response test in the US

First-of-its-kind precision medicine test to predict a cancer patient’s response to an Immune Checkpoint Inhibitor (ICI)


Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
News | February 24, 2022

Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine

100% efficacy against severe Covid-19 disease and hospitalizations


Study details Proof-of-Concept for Covid-19 detection via saliva screening
Medical Device | February 24, 2022

Study details Proof-of-Concept for Covid-19 detection via saliva screening

Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR


CanSinoBIO's Convidecia approved as heterologous booster in China
News | February 21, 2022

CanSinoBIO's Convidecia approved as heterologous booster in China

Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants


Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus
News | February 21, 2022

Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus

CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan


Centauri Therapeutics closes £ 24 million Series A investment round
Startup | February 17, 2022

Centauri Therapeutics closes £ 24 million Series A investment round

Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform


Moderna announces expansion in key Asian markets
News | February 16, 2022

Moderna announces expansion in key Asian markets

New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong


Novavax Covid-19 vaccine well tolerated in paediatric population
Biotech | February 11, 2022

Novavax Covid-19 vaccine well tolerated in paediatric population

Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified


Indian govt. places order for five crore doses of Corbevax
News | February 05, 2022

Indian govt. places order for five crore doses of Corbevax

Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius


USFDA approves first generic of Restasis
Drug Approval | February 03, 2022

USFDA approves first generic of Restasis

Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug